BLOG

contagion

Vaxart Has Developed the First Oral Investigational COVID-19 Vaccine

South San Francisco-based Vaxart recently announced they had entered into a phase 1 trial for their VXA-CoV2-1 vaccine. Vaxart is a biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform.